Triple
T6003748
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Loxo Oncology |
E133655
|
entity |
| Predicate | regulatoryMilestone |
P9662
|
FINISHED |
| Object | first TRK inhibitor approved in the United States |
—
|
LITERAL FINISHED |
Provenance (3 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c00872444c8190bfaf1739dcec765c |
elicitation | completed |
| NER | batch_69c04f0f63148190826198281dce3713 |
ner | completed |
| PD | batch_69c049e3316c819087ea635fa7ee8472 |
pd | completed |
Created at: March 22, 2026, 4:06 p.m.